Wolverine Asset Management’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CANO.WS
Wolverine Asset Management's CANO.WS Position: Q4 2023 in Review
Wolverine Asset Management sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 2,779 shares — an estimated $138 sold.
Wolverine Asset Management first reported a position in CANO.WS in Q3 2023 and held it in 1 quarter. The position peaked at $138 in Q3 2023. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.
- Wolverine Asset Management reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
- Wolverine Asset Management sold 2,779 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $138.
- Wolverine Asset Management first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q3 2023 and held it in 1 quarter.
- Wolverine Asset Management's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $138 in Q3 2023.
- 2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.
Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.